Imperial Petroleum Inc. Declares Dividend on Series A Preferred Shares

Rhea-AI Summary

DarioHealth (NASDAQ: DRIO) announced a private placement to sell 2,713,180 shares of common stock (or equivalents) at $6.45 per share for expected gross proceeds of approximately $17.5 million.

The closing is expected on or about September 23, 2025, subject to customary closing conditions. The company intends to use net proceeds for general corporate purposes and will file a registration statement with the SEC to register resale of the placed shares. The offering is being made in reliance on exemptions under Section 4(a)(2) of the Securities Act and/or Regulation D and applicable state securities laws.

Positive

• Gross proceeds of approximately $17.5 million
• Issuance of 2,713,180 shares at $6.45 per share
• Company will file SEC registration to permit resale of placed shares

Negative

• Issuance increases outstanding shares by 2,713,180 (potential shareholder dilution)

News Market Reaction

+0.08%

2 alerts

+0.08% News Effect

+2.5% Peak Tracked

+$72K Valuation Impact

$90M Market Cap

0.3x Rel. Volume

On the day this news was published, DRIO gained 0.08%, reflecting a mild positive market reaction. Argus tracked a peak move of +2.5% during that session. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $72K to the company's valuation, bringing the market cap to $90M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Shares offered: 2,713,180 shares Offering price: $6.45 per share Gross proceeds: $17.5 million +3 more

6 metrics

Shares offered 2,713,180 shares Common stock (or equivalents) in private placement

Offering price $6.45 per share Purchase price in private placement

Gross proceeds $17.5 million Expected aggregate gross proceeds before expenses

Closing date September 23, 2025 Expected closing of the private placement

Section 4(a)(2) Section 4(a)(2) Exemption relied on under the Securities Act of 1933

Regulation D Regulation D Exemption relied on for private placement

Market Reality Check

Price: $10.02 Vol: Relative volume at 1.2x t...

normal vol

$10.02 Last Close

Volume Relative volume at 1.2x the 20-day average, with shares traded 1,293,536 vs 1,081,702 average. normal

Technical Price $4.26 is trading above the 200-day MA at $3.58, after a recent -6.67% move.

Peers on Argus

IMPP fell 6.67% while closely scored peers showed mixed, smaller moves: DLNG -0....

1 Up

IMPP fell 6.67% while closely scored peers showed mixed, smaller moves: DLNG -0.26%, MMLP +0.39%, KNOP +0.47%, SMC -0.07%, TEN -0.25%. Momentum scanner only flagged NFE at +4.62%, suggesting stock-specific dynamics for IMPP rather than a broad midstream/energy move.

Historical Context

5 past events · Latest: Dec 05 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Dec 05	Results date set	Neutral	-0.8%	Scheduled Q3 and nine-month 2025 results release and conference call.
Nov 28	Capital offering	Negative	-21.8%	Announced $60M registered direct offering with warrants to institutional investors.
Sep 12	Preferred dividend	Positive	+9.6%	Declared $0.546875 dividend on 8.75% Series A preferred shares.
Sep 05	Earnings update	Positive	+2.0%	Reported Q2 2025 results with profitability and strong cash position.
Aug 29	Results date set	Neutral	+3.0%	Announced timing and call details for Q2 and H1 2025 results.

Pattern Detected

IMPP’s stock has generally reacted in line with news tone: dividend and earnings updates saw modest gains, while the recent $60M registered direct offering coincided with a sharp decline.

Recent Company History

Over the last few months, IMPP news has focused on capital raising, dividends, and operating performance. A $60.0M registered direct offering on Nov 28, 2025 was followed by a -21.83% move, highlighting sensitivity to dilution. By contrast, recurring Series A preferred dividends, including one on Sep 12, 2025 that led to a 9.56% gain, and solid Q2 2025 results with profitability and zero debt, were associated with positive or modestly positive reactions.

Market Pulse Summary

This announcement describes a private placement of 2,713,180 shares at $6.45 per share for expected ...

Analysis

This announcement describes a private placement of 2,713,180 shares at $6.45 per share for expected gross proceeds of $17.5 million, relying on exemptions under Section 4(a)(2) and Regulation D. Contextually, IMPP has recently combined capital-raising steps with recurring preferred dividends and solid profitability. Investors may watch how additional funding interacts with existing offerings, prior dividend practices, and upcoming financial disclosures when assessing capital structure and dilution risk.

Key Terms

private placement, Section 4(a)(2), Regulation D, registration statement

4 terms

private placement financial

"today announced a private placement for the purchase and sale of 2,713,180"

A private placement is a way for companies to raise money by selling securities directly to a small group of investors instead of through a public offering. This process is often quicker and less regulated, making it similar to offering a special, exclusive investment opportunity to select individuals or institutions. For investors, it can provide access to unique investment options that are not available on public markets.

Section 4(a)(2) regulatory

"exemption from the registration requirement under Section 4(a)(2) of the Securities"

Section 4(a)(2) is a part of U.S. securities laws that allows companies to sell their stock directly to certain investors without registering the sale with regulators. This process is often used for private placements, making it easier and faster for companies to raise money from knowledgeable or institutional investors. It matters to investors because it provides an alternative way to buy shares, often with fewer disclosures and lower costs.

Regulation D regulatory

"and/or Regulation D promulgated thereunder, and applicable state securities laws."

Regulation D is a set of rules that govern how companies can raise money from investors without going through the full process required for public stock offerings. It provides simplified options for private placements, making it easier for companies to seek investments from a smaller group of investors. For investors, it offers opportunities to invest in private companies, often with fewer restrictions, but also with different levels of risk and disclosure.

registration statement regulatory

"has agreed to file a registration statement with the Securities and Exchange"

A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.

AI-generated analysis. Not financial advice.

ATHENS, Greece, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Imperial Petroleum Inc. (Nasdaq: IMPP) (the “Company”), a ship-owning company providing petroleum products, crude oil, and drybulk seaborne transportation services, today announced a dividend of $0.546875 per share on its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Shares”), payable on December 30, 2025 to holders of record as of December 24, 2025. The dividend payment relates to the period from the last dividend payment date for the Series A Preferred Shares on September 30, 2025 through December 29, 2025.

There are 795,878 Series A Preferred Shares outstanding as of the date hereof. The Series A Preferred Shares trade on the Nasdaq Capital Market under the ticker symbol “IMPPP”.

ABOUT IMPERIAL PETROLEUM INC.

IMPERIAL PETROLEUM INC. is a ship-owning company providing petroleum products, crude oil and drybulk seaborne transportation services. The Company owns a total of nineteen vessels on the water - seven M.R. product tankers, two suezmax tankers and ten drybulk carriers - with a total capacity of 1,195,000 deadweight tons (dwt) and has contracted to acquire an additional three drybulk carriers of 164,400 dwt aggregate capacity. Following these deliveries, the Company’s fleet will count a total of 22 vessels with an aggregate capacity of 1.4 million dwt. IMPERIAL PETROLEUM INC.’s shares of common stock and 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock are listed on the Nasdaq Capital Market and trade under the symbols “IMPP” and “IMPPP,” respectively.

Forward-Looking Statements

Matters discussed in this release may constitute forward-looking statements. Forward-looking statements reflect our current views with respect to future events and financial performance and may include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts. The forward-looking statements in this release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, management’s examination of historical operating trends, data contained in our records and other data available from third parties. Although IMPERIAL PETROLEUM INC. believes that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, IMPERIAL PETROLEUM INC. cannot assure you that it will achieve or accomplish these expectations, beliefs or projections. Risks and uncertainties are further described in reports filed by IMPERIAL PETROLEUM INC. with the U.S. Securities and Exchange Commission.

Company Contact:

Fenia Sakellaris

IMPERIAL PETROLEUM INC.

E-mail: info@imperialpetro.com

FAQ

What size is the DarioHealth (DRIO) private placement announced September 2025?

DarioHealth offered 2,713,180 common shares for expected gross proceeds of about $17.5 million.

At what price per share is DarioHealth (DRIO) selling shares in the private placement?

The placement price is $6.45 per share.

When is the closing date for the DarioHealth (DRIO) private placement?

The closing is expected to occur on or about September 23, 2025, subject to customary conditions.

How will DarioHealth (DRIO) use the proceeds from the September 2025 offering?

The company intends to use net proceeds for general corporate purposes.

Will DarioHealth (DRIO) register the resale of shares issued in the private placement?

Yes; the company has agreed to file a registration statement with the SEC to register resale of the placed shares.

Under what authority is the DarioHealth (DRIO) private placement being sold?

The offering is being made in reliance on exemptions under Section 4(a)(2) of the Securities Act and/or Regulation D and applicable state securities laws.